Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Crisp

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Augmentative and Alternative Communication (Baltimore, Md. : 1985)|May 23, 2025
Crossing the communication chasmMelissa Crisp-Cooper
FEBS Letters|May 14, 2008
The nuclear envelope as an integrator of nuclear and cytoplasmic architectureMelissa Crisp, Brian Burke
Symposia of the Society for Experimental Biology|November 30, 2004
Nuclear envelope dynamics during mitosisBrian Burke, Melissa Crisp, Davide Salina
Novartis Foundation Symposium|March 19, 2005
Aspects of nuclear envelope dynamics in mitotic cellsBrian Burke, Catherine Shanahan, Davide Salina, et al.
The Journal of Cell Biology|August 29, 2007
Functional association of Sun1 with nuclear pore complexesQian Liu, Nelly Pante, Tom Misteli, et al.
The Journal of Cell Biology|December 29, 2005
Coupling of the nucleus and cytoplasm: role of the LINC complexMelissa Crisp, Qian Liu, Kyle Roux, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2011
Discovery, synthesis and SAR analysis of novel selective small molecule S1P4-R agonists based on a (2Z,5Z)-5-((pyrrol-3-yl)methylene)-3-alkyl-2-(alkylimino)thiazolidin-4-one chemotypeMariangela Urbano, Miguel Guerrero, Subash Velaparthi, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2011
Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P₄-R) agonistsMiguel Guerrero, Mariangela Urbano, Jian Zhao, et al.
Molecular Cancer Therapeutics|September 3, 2011
Identification of small-molecule inhibitors of the colorectal cancer oncogene Krüppel-like factor 5 expression by ultrahigh-throughput screeningAgnieszka B Bialkowska, Melissa Crisp, Thomas Bannister, et al.
Science Translational Medicine|June 9, 2022
The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccinationRobert J Benschop, Jay L Tuttle, Lin Zhang, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Augmentative and Alternative Communication (Baltimore, Md. : 1985)|May 23, 2025
Crossing the communication chasmMelissa Crisp-Cooper
FEBS Letters|May 14, 2008
The nuclear envelope as an integrator of nuclear and cytoplasmic architectureMelissa Crisp, Brian Burke
Symposia of the Society for Experimental Biology|November 30, 2004
Nuclear envelope dynamics during mitosisBrian Burke, Melissa Crisp, Davide Salina
Novartis Foundation Symposium|March 19, 2005
Aspects of nuclear envelope dynamics in mitotic cellsBrian Burke, Catherine Shanahan, Davide Salina, et al.
The Journal of Cell Biology|August 29, 2007
Functional association of Sun1 with nuclear pore complexesQian Liu, Nelly Pante, Tom Misteli, et al.
The Journal of Cell Biology|December 29, 2005
Coupling of the nucleus and cytoplasm: role of the LINC complexMelissa Crisp, Qian Liu, Kyle Roux, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2011
Discovery, synthesis and SAR analysis of novel selective small molecule S1P4-R agonists based on a (2Z,5Z)-5-((pyrrol-3-yl)methylene)-3-alkyl-2-(alkylimino)thiazolidin-4-one chemotypeMariangela Urbano, Miguel Guerrero, Subash Velaparthi, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2011
Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P₄-R) agonistsMiguel Guerrero, Mariangela Urbano, Jian Zhao, et al.
Molecular Cancer Therapeutics|September 3, 2011
Identification of small-molecule inhibitors of the colorectal cancer oncogene Krüppel-like factor 5 expression by ultrahigh-throughput screeningAgnieszka B Bialkowska, Melissa Crisp, Thomas Bannister, et al.
Science Translational Medicine|June 9, 2022
The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccinationRobert J Benschop, Jay L Tuttle, Lin Zhang, et al.
Pageof 2